Chilco River Holdings Enters Premium Alcohol Beverage Sector, Targets Strategic Acquisitions to Accelerate Growth
Chatsworth, California--(Newsfile Corp. - May 29, 2025) - Chilco River Holdings, Inc. (OTC Pink: CRVH) ('Chilco' or the 'Company'), a rising force in brand acceleration, is thrilled to announce a transformative leap into the booming premium alcoholic beverage industry. This bold pivot marks the beginning of an ambitious growth strategy centered on acquiring standout brands and building a powerhouse portfolio in one of the most dynamic consumer markets.
The company is currently engaged in advanced negotiations with multiple acquisition targets including innovative upstarts and established premium labels. Chilco is positioning itself at the forefront of a surging industry driven by demand for craft spirits, ready-to-drink cocktails (RTDs), and luxury lifestyle beverages.
'The premium beverage space is exploding with opportunity,' stated, Chief Executive Officer, William Lovett. 'Our entry into this market is a game-changer, and we're already in deep discussions with brands that we believe can supercharge our trajectory and deliver lasting value to our shareholders.'
As part of this strategic realignment, the Company has formally canceled prior agreements with Leuffer Desarrollos SA de CV, American Hemp Brands, Inc., and L Myers Associates. These transactions were never consummated and no longer reflect the Company's core business objectives. This provides a fresh start and allows Chilco to dedicate full resources and strategic efforts toward the premium alcohol sector.
'This marks a clean slate and a bold new direction for Chilco,' continued Lovett. 'The premium beverage space is full of energy and opportunity, and we are excited to dive in. With the right strategy and execution, we believe we can build something truly impactful for our shareholders.'
In parallel with its renewed business direction, Chilco is proud to announce it has achieved Pink Current Information status with OTC Markets. This milestone not only underscores the Company's commitment to transparency but also unlocks powerful new levers for growth, including M&A activity, capital raising, and the onboarding of top-tier leadership.
With a clear vision and renewed focus, Chilco River Holdings is moving forward with determination and purpose. The Company is committed to transparency, disciplined execution, and consistent communication with shareholders. As it enters the premium alcohol space, Chilco is well-positioned to seize new opportunities and build lasting value in one of today's most dynamic markets.
About Chilco River Holdings, Inc.
Chilco River Holdings is a U.S.-based brand accelerator focused on identifying and acquiring premium consumer products with high-growth potential. The Company is currently targeting acquisitions in the premium alcohol beverage sector, including spirits, and ready-to-drink brands.
For more information, please contact:
Investor Relations
Chilco River Holdings, Inc.
Email: [email protected]
Website: www.chilcoriver.com
Forward-Looking Statements:
This press release contains forward-looking statements, including statements regarding the Company's strategic direction, acquisition plans, and anticipated growth. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results may differ materially due to factors such as market conditions, due diligence outcomes, and regulatory approvals. Chilco River Holdings undertakes no obligation to update these statements, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/253741
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
PROPOSED RTO, $35 MILLION FINANCING & CONSOLIDATION OF THE PECOY COPPER PORPHYRY PROJECT IN SOUTHERN PERU
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ VANCOUVER, BC, June 11, 2025 /CNW/ - Priyanka Capital Inc. ("Priyanka" or the "Company") is pleased to announce that it has entered into a letter of intent with Pecoy Copper Limited, a special purpose vehicle ("Pecoy SPV") founded by the former management team of Nomad Royalty Company Ltd. The proposed transaction is intended to result in a reverse takeover of the Company by Pecoy SPV (the "RTO"). The Transaction Pecoy SPV has recently signed a series of binding acquisition and option agreements (the "Acquisition Agreements") with Copper X Mining Corp., Pembrook Copper Corp., and various private third parties to consolidate ownership of the Pecoy copper-gold-molybdenum project (the "Pecoy Project" or "Pecoy") located in southern Peru. Upon closing of the Acquisition Agreements and the RTO (the "Transaction"), the Company, to be renamed Pecoy Copper Corp. (the "Pecoy Copper"), will directly or indirectly either own, or hold an option to acquire, all of the properties comprising the Pecoy Project. Closing of the RTO is conditional upon receiving conditional approval (the "TSXV Conditional Approval") from the TSX Venture Exchange ("TSXV") for the listing of the common shares of the Company on the TSXV. As part of the Transaction, Pecoy SPV has engaged Canaccord Genuity Corp. ("Canaccord Genuity") to act as lead agent and sole bookrunner in connection with a private placement of subscription receipts for gross proceeds of approximately $35 million. Management, officers and affiliates of Pecoy Copper intend to subscribe for up to $8.5 million of the private placement. Creating A New Leading Copper-Gold Focused Development Company The Transaction would unlock the full potential of one of the world's largest undeveloped copper-gold-molybdenum porphyry deposits by consolidating its ownership for the first time. The benefits of this transaction to the Company are expected to include the following: Pecoy Copper represents a rare opportunity to acquire one of the world's largest undeveloped copper-gold-molybdenum porphyry deposits, with an Inferred Mineral Resource of approximately 865 million tonnes grading 0.34% Cu, 0.012% Mo, 0.05 g/t Au, and 1.33 g/t Ag; containing 6.5 billion pounds of copper and offering substantial resource expansion potential. The Pecoy Project has over US$65 million in historical investment since its discovery in 2011 that supports the potential for a large-scale, low-strip, open-pit operation at a favorable low elevation of 1,650 metres above sea level. Significant exploration upside exists not only at Pecoy but also across more than 19,772 hectares of surrounding concessions, including the Tororume Project, with multiple early and advanced-stage targets already identified. To date, only 48,576 metres of diamond drilling have been completed at Pecoy, with near-term priority targets in the center of the pit and south breccia zones. Initial metallurgical testing indicates a high copper recovery rate of 88%, with no deleterious elements detected. Further testwork will assess the potential to produce a molybdenum concentrate through Cu-Mo separation. The project benefits from robust infrastructure and long-term community agreements, including a 30-year surface access agreement with local communities, active drill permits, and an operational exploration camp — all of which support near-term drilling and development efforts. Peru is a top-tier mining jurisdiction, consistently ranked among the world's leading producers of copper, gold, silver, tin and zinc. Mining is a key contributor to the country's GDP and the global supply of metals. Strategically located within the Southern Peru Porphyry Copper Belt, Pecoy sits at the northwestern end of a district that hosts world-class deposits such as Cerro Verde, Cuajone, Toquepala, Quellaveco, Zafranal, and Cerro Negro, making it ideally positioned for rapid advancement. Proceeds from the upcoming financing will be used to complete 30,000 metres of exploration drilling, conduct metallurgical and geotechnical studies, and advance the Pecoy Project toward a Preliminary Economic Assessment (PEA). The Offering Pecoy SPV has entered into an engagement letter with Canaccord Genuity to act as lead agent and sole bookrunner, on its own behalf and on behalf of a syndicate of agents (collectively, the "Agents"), in connection with an offering of subscription receipts (the "Subscription Receipts") at a price of $0.60 per Subscription Receipt (the "Offering Price") for gross proceeds of approximately $35 million (the "Offering"). The Offering shall be conducted on a "best efforts" private placement basis. Pecoy SPV has also granted the Agents an option (the "Agents' Option") to sell up to such number of additional Subscription Receipts as is equal to 15% of the number of Subscription Receipts sold under the Offering at the Offering Price. The Agents' Option shall be exercisable, in whole or in part, at any time up to 48 hours prior to closing of the Offering. Upon closing of the Offering, the gross proceeds of the Offering, less certain payments to the Agents on account of their expenses and partial commission, shall be held in escrow until certain conditions are met, including receipt of the TSXV Conditional Approval and the satisfaction of all conditions to closing of the Acquisition Agreements. Each Subscription Receipt shall be automatically exchanged for, without payment of any additional consideration and without further action on the part of the holder thereof, one common share of Pecoy SPV upon satisfaction of the escrow release conditions prior to the date that is 90 days following the Offering closing date. Upon closing of the RTO, all Pecoy SPV shares, including the shares issuable under the Subscription Receipts, shall be exchanged for shares of Pecoy Copper. Additional details of the Offering shall be announced upon closing of the Offering. The net proceeds of the Offering shall be used to fund the cash consideration in connection with the Acquisition Agreements, advance exploration and development of the Pecoy Copper Project, as well as for working capital and general corporate purposes. The completion of the foregoing transactions is subject to a number of closing conditions, including shareholder approval in certain circumstances and the receipt of the TSXV Conditional Approval. "Pecoy Copper is a rare opportunity to unlock one of the world's largest undeveloped copper-gold-molybdenum systems," said Vincent Metcalfe, CEO, Director and Co-Founder of Pecoy Copper. "With a large-scale resource already defined, exceptional exploration potential, and long-term community agreements in place, we are well positioned to accelerate development. Pecoy Copper is set to play a meaningful role in Peru's mining future and the global copper supply chain. We're thrilled to launch this new chapter with the strong support of all our stakeholders." "Having worked in Peru for over 10 years, I, like Mr. Metcalfe, have continuously sought 'The Project' that combines established value, scale, exploration potential, and a clear development roadmap," commented Paul Matysek, Chairman and Co-Founder of Pecoy Copper. "Historically, the advancement of the project has been hampered by fractured ownership, but uniting both parts of the deposit for the first time is a major milestone that clears the way for further development. Our experienced team, an established resource with significant upside, a 30-year community agreement, and proximity to infrastructure, are key elements that will propel Pecoy Copper to success." Pecoy Copper Board and Management Upon closing of the Transaction, the management and board of the Company shall be reconstituted to lead the development of the Pecoy Project. The board will consist of Paul Matysek (Chair), Luis Zapata, Vincent Metcalfe, Jerrold Annett, Jose Luque and two additional nominees to be determined. The management team will be led by Vincent Metcalfe as President and CEO and will include Vincent Cardin-Tremblay as Chief Geological Officer and Luis Zapata as Managing Director (Peru) in addition to other management appointments to be determined. Vincent Metcalfe – President, CEO & DirectorAccomplished senior executive with over 20 years of experience building companies and advancing mining projects. Brings deep expertise in M&A, financial management, and raising capital. Co-Founder of Evolve Royalties and former CEO and Chair of Nomad Royalty, sold to Sandstorm. Recipient of the YMP Peter Munk Award for leadership and innovation in mining. Paul Matysek – ChairmanSerial entrepreneur, M&A specialist, and geologist with over 40 years of experience in the mining industry. Since 2007 as CEO or Chairman, Mr. Matysek has sold six publicly listed companies, in aggregate worth over $3 billion, with two assets going into commercial production: Bethune Mine - Potash One and Lindero Mine - Goldrock Mines. Most recently, he was the CEO of Gold X Mining Corp. that was sold to Grand Columbia Gold Corp. for approximately $365 million. Mr. Matysek is a recipient of the EY Entrepreneur of the Year for Mining & Resources. Vincent Cardin-Tremblay – Chief Geological OfficerAccomplished geologist with extensive exploration and mining experience across the Americas and Africa. Served as VP–Geology at Nomad Royalty Company prior to its acquisition by Sandstorm Gold. He has also held senior technical roles at Harte Gold, Golden Star, and IAMGOLD, and worked with Freeport-McMoRan and Glencore. Luis Zapata – Managing Director – Peru, DirectorFinance and mining executive with 15 years of experience in resource development. Mr. Zapata has financed and operated numerous mining and energy projects. Currently serves as CEO of a private Peruvian gold producer, and as President & Director of Axcap Ventures. Held senior roles including Head of Latin American Equities at Canaccord Genuity. Jerrold Annett – DirectorGlobal mining and capital markets specialist, and metallurgist with 29+ years of experience in mining. Most recently responsible for leading Capstone Copper's investor relations, marketing and metal sales activities. Worked at Teck Resources and Falconbridge as a metallurgist and in metal sales, followed by 10 years in capital markets, including with Scotiabank where he was Head of Mining Institutional Sales. He is a P. Eng. and has a Bachelor of Applied Science in Mining and Mineral Engineering from Queen's University. Jose Luque – DirectorSenior executive with over 30 years of experience building shareholder value. Possesses profound insights in mining operations, M&A, organizational leadership, project management, financial management and restructuring. Serves as CEO of Gea Mining which promotes the development of underground mines and exploration of copper porphyry targets. Held senior executive positions in several S&P companies in the United States and Latin America. Pecoy – Resource Statement Pecoy - Inferred Resources Cut-Off Tonnage Grade Contained % Cu M tonnes Cu % Mo % Au ppm Ag ppm B Lbs Cu 0.15 2,278 0.24 0.010 0.03 1.10 12,053 0.20 1,302 0.29 0.011 0.04 1.23 8,324 0.23 865 0.34 0.012 0.05 1.33 6,451 0.25 742 0.36 0.012 0.05 1.37 5,889 Notes: 1. Mineral Resources are not Mineral Reserves and have not demonstrated economic viability. 2. The MRE has been categorized in accordance with the CIM Definition Standards (CIM, 2014). 3. All figures are rounded to reflect the relative accuracy of the estimates. Minor discrepancies may occur due to rounding to appropriate significant figures. 4. The Mineral Resource was estimated by Ms. Muñoz QP (MAIG) of Mining Plus, Independent Qualified Person under NI 43-101. 5. The effective date of the Mineral Resource Estimate is 30 April 2025. 6. The Mineral Resource is reported inside a whittle pit shell with a cut-off grade of 0.23 % copper, estimated using a copper price of US$/lb 3.25, molybdenum price of US$ 8/lb, gold price of US$ 1,400/oz and silver price of US$ 20/oz. 7. Mining Plus is not aware of any legal, political, environmental, or other risks that could materially affect the potential development of the Mineral Resource Estimate Conditions to Closing The completion of the Transaction will be subject to a number of conditions customary for a transaction of this nature, including but not limited to entering into a definitive agreement in respect of the Transaction, the receipt of required regulatory and corporate approvals, approval of the Amalgamation by the shareholders of Pembrook, completion of the Acquisition Agreements; and the closing of the Offering. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. About the Pecoy Project The Pecoy Project covers an area of 9,975 hectares (ha) across 19 concessions without prior mining activity. The Project is located along the northwest extension of the Southern Peru Porphyry Copper Belt, a metallogenic corridor that hosts several large-scale porphyry copper deposits. The project area is underlain by intrusive rocks of the Coastal Batholith, including porphyritic granites and granodiorites, which are intruded by hydrothermal breccias, dacitic porphyries and multitude of dikes. Alteration consists of widespread sericitization (chlorite and sericite alteration) and silicification near the center of the system, grading downward to potassic and outward to propylitic alteration. Additionally, there are narrow gold-bearing quartz veins in the periphery of the system. Mineralization is associated with a porphyry copper system featuring well-developed supergene and primary zones, where copper occurs mainly as chalcocite and chalcopyrite. At surface, mineralization is almost totally oxidized. Leached, supergene, copper oxide, enrichment and transitional zones of the porphyry copper deposit are leached to a maximum depth of 200 to 240 m. The secondary enrichment zone has an average approximate thickness of 20 m, with a minimum of 2 meters and a maximum of 70 m. The primary mineralization extends to depths greater than 1,000 m, with significant copper and gold values hosted in breccia bodies and porphyritic intrusions and remains open laterally and at depth. The Pecoy Project is situated at the northwest end of the Southern Peru Porphyry Copper Belt which also hosts the large Cuajone, Toquepala, Quellaveco, Cerro Verde, Zafranal, and Cerro Negro porphyry deposits. Porphyry copper mineralization occurs above multi-phase intrusive complexes and can produce large tonnage, low grade copper deposits with possible by-products of gold and molybdenum. To date, the Pecoy Project includes 121 diamond drill holes totaling 48,576 m of drilling. Drilling has consistently intersected porphyry-style mineralization, with copper, gold, silver, and molybdenum values continuously distributed across the drilled area. The technical disclosure in this news release has been reviewed and approved by Vincent Cardin-Tremblay, P. Geo., who is a Qualified Person as defined by National Instrument 43-101 of the Canadian Securities Administrators. About the Company The Company is a reporting issuer in the Provinces of British Columbia and Alberta. The Company's shares are not currently listed on any stock exchange and it is presently engaged in identifying and evaluating potential business opportunities. ON BEHALF OF THE BOARD OF DIRECTORS Robert Dubeau, President, CEO and Director Suite 1500, 1055 West Georgia Street, Vancouver, BC V6E 4N7 Telephone: 778 837 8550 Email: bobbydubeau@ Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements that may be deemed "forward-looking statements". All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur and specifically include statements regarding the Transaction, the Amalgamation; the timing and potential completion of the Transaction; satisfaction of the conditions precedent to closing of the Transaction; the Name Change; the Board Re-Constitution; and the Company's business and strategic plans. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward looking statements. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change. SOURCE Pecoy Copper View original content:
Associated Press
11 minutes ago
- Associated Press
Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025
CAMBRIDGE, MA / ACCESS Newswire / June 11, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor event: Barclays Speaking the Science Call Series, on Monday, June 16th at 10:00am ET A live webcast of this presentation will be available under 'Events and Presentations' in the Investors section of the Moderna website. A replay of this webcast will be archived on Moderna's website for at least 30 days following the presentation. About Moderna Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines. Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. Investors: Lavina Talukdar Senior Vice President & Head of Investor Relations 617-209-5834 [email protected] SOURCE: Moderna, Inc. press release
Associated Press
11 minutes ago
- Associated Press
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
NEWARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT), today reported its financial results for the third quarter and first nine months of fiscal year 2025 ended April 30, 2025. 'We are pleased to have completed our merger with Cyclo Therapeutics and look forward to reporting the topline data from the 48-week interim analysis of the pivotal Phase 3 TransportNPC ™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 anticipated later this month,' said Howard Jonas, Chief Executive Officer, Executive Chairman and Chairman of the Board of Rafael Holdings. Mr. Jonas added, 'We have enhanced our financial position with the closing of a $25 million rights offering earlier this month which will support advancing this potential new treatment option for patients suffering from this rare genetic disease.' Rafael Holdings, Inc. Third Quarter Fiscal Year 2025 Financial Results As of April 30, 2025, we had cash and cash equivalents of $37.9 million. On June 4, 2025, the Company announced the closing of a $25 million rights offering, which, including the funding of the backstop commitment by the Jonas family, raised net proceeds of $24.9 million after deduction of certain expenses incurred in connection with the offering. For the three months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $4.8 million, or $0.19 per share, versus a net loss of $32.4 million, or $1.36 per share in the year ago period. The year over year decrease in net loss is attributable to non-cash items, primarily unrealized losses of $1.4 million on the Company's investment in Cyclo equity which we purchased in advance of the potential merger in the current period versus $4.4 million in the year ago period, combined with an in-process R&D expense of $89.9 million related to the acquisition of Cornerstone, partially offset by a $31.3 million recovery of receivables from Cornerstone in the year ago period. Research and development expenses were $3.0 million for the three months ended April 30, 2025, compared to $1.5 million in the year ago period. The year over year increase relates to the inclusion in the current year period of spending at Cyclo Therapeutics following the March 25, 2025 merger and the activity of Cornerstone and Day Three which were consolidated with Rafael Holdings during fiscal 2024. General and administrative expenses were $3.2 million for the three months ended April 30, 2025, compared to $1.9 million in the year ago period. The year over year increase relates to the inclusion of Cyclo Therapeutics following closing of the merger, and the activity of Cornerstone and Day Three, following their consolidation. Rafael Holdings, Inc. First Nine Months Fiscal Year 2025 Financial Results For the nine months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $18.4 million, or $0.73 per share, versus a net loss of $29.9 million, or $1.26 per share in the year ago period. The year over year decrease in net loss is attributable to in-process R&D expense of $89.9 million related to the acquisition of Cornerstone net with a $31.3 million recovery of receivables from Cornerstone in the year ago period and $3.2 million in unrealized gains on the Company's investment in Cyclo equity. Research and development expenses were $5.3 million for the nine months ended April 30, 2025, compared to $2.6 million in the year ago period. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. For the nine months ended April 30, 2025, general and administrative expenses were $8.3 million compared to $6.5 million in the same period in the prior year. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. About Rafael Holdings, Inc. Rafael Holdings, Inc. holds interests in clinical and early-stage pharmaceutical and certain other companies, including our wholly owned subsidiary, Cyclo Therapeutics, LLC, a clinical stage biotechnology company dedicated to developing Rafael's lead clinical candidate, Trappsol® Cyclo™, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 ('NPC1'), a rare, fatal, and progressive genetic disorder. Rafael also holds majority equity interests in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company, Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their existing cannabis offerings. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the potential, safety, efficacy, and regulatory and clinical progress of our product candidates; plans regarding the further evaluation of clinical data; and the potential of our pipeline, including our internal cancer metabolism research programs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those disclosed under the caption 'Risk Factors' in our Annual Report on Form 10-K for the year ended July 31, 2024, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Contact: Barbara Ryan [email protected] (203) 274-2825
